Dennis Langer, Director at Dicerna Pharmaceuticals Inc (DRNA), sold 47,532 shares at $3.52 ($167K) on 2016-11-16, disclosed to the SEC on 2016-11-17.
Open-market sale of $167k DRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.52 | 23,766 | $84K | 50.0% |
| 2 | $3.52 | 23,766 | $84K | 50.0% |
| Total | $3.52 avg | 47,532 | $167K | 100% |
| Filing → |
| MYGN | SELL | 2021-08-05 | $1.0M | — | Filing → |
| DRNA | SELL | 2018-08-17 | $613K | — | Filing → |
| MYGN | SELL | 2018-06-08 | $1.6M | — | Filing → |